Journal of Neuro-Oncology

Article	Citations
Complete resolution of peritumoral FLAIR hyperintensity is infrequent in surgically treated patients with intracranial meningiomas	65
Harnessing imaging biomarkers for glioblastoma metastasis diagnosis: a correspondence	62
Relationship between apparent diffusion coefficient and survival as a function of distance from gross tumor volume on radiation planning MRI in newly diagnosed glioblastoma	51
Response to correspondence on an exploratory prospective phase II study of preoperative neoadjuvant bevacizumab and temozolomide for newly diagnosed glioblastoma	45
Whole Body-MRI assessment of peripheral lesions in patients with NF2-related schwannomatosis on systemic bevacizumab	43
Whole exome sequencing study of adamantinomatous craniopharyngioma reveals the mutational characteristics of recurrent cases	41
Preoperative meningioma vascularity index is associated with significantly increased intraoperative blood loss and greater risk of subtotal resection	41
Factors influencing timely diagnosis in neurolymphomatosis	39
Repeat stereotactic radiosurgery for treatment of brain metastases locally recurrent following initial radiosurgery	38
Comment on: “Anatomical distribution and prognostic heterogeneity in glioma: unique clinical features of occipital glioblastoma”	38
Thalamic involvement in glioblastoma is associated with lower risk of seizures: a retrospective cohort study	37
Development of a recursive partitioning analysis for prediction of radiation necrosis following single-fraction stereotactic radiosurgery for intact brain metastases	37
Fractionated stereotactic radiotherapy in craniopharyngiomas: A systematic review and single arm meta-analysis	36
Glioblastoma cell motility and invasion is regulated by membrane-associated heat shock protein Hsp70	36
Variables associated with 90-day readmission following craniotomy for tumor in the pediatric population	35
Multimodal pathomics and clinical features predict postresection permanent hydrocephalus in pediatric medulloblastoma	33
Oncological value of MRI in brain metastasis: exploring the potential of combining post-contrast T1 TSE (SPACE) and T1 GRE (MPRAGE) for stereotactic radiosurgery planning and surveillance	33
Letter: Exploring cell-free DNA as a biomarker for assessing tumor burden in metastatic spine disease	33
Early outcomes of Gamma Knife stereotactic radiosurgery for symptomatic intracranial meningiomas in octogenarians: technique analysis and rationale	33
Distinct size and spatial distribution patterns of ALK-inhibitor-naïve versus ALK-inhibitor exposed ALK-positive NSCLC brain metastases	32
Different clinical and cytogenetic features of primary skull base meningiomas and non-skull base meningiomas	30
Improved survival and intracranial tumor control of EGFR-mutated NSCLC patients with newly developed brain metastases following stereotactic radiosurgery and EGFR-TKI: a large retrospective cohort stu	30
The trial effect in patients with glioblastoma: effect of clinical trial enrollment on overall survival	29
Repeated responders to bevacizumab combination treatment in recurrent glioblastoma: a retrospective case study	28
Predictors of brain metastases in patients with oligometastatic solid tumours treated with stereotactic body radiation therapy	28

Update of NK cell therapy in pediatric brain tumors	28
Neuropsychological functioning during chemotherapy with temozolomide in high-grade glioma patients: a retrospective single centre study	28
Efficacy of endoscopic management of primary central nervous system lymphoma: a multicentric study and literature review	27
Maximal resection improves survival in MGMT methylated very elderly glioblastoma patients	27
Spatial invasion patterns of temporal lobe glioblastoma after complete resection of contrast-enhancing tumor	26
Prognostic factors among patients with brain metastases from cancer of unknown primary site	26
The 5-factor modified frailty index as a prognostic factor for stereotactic radiosurgery in meningioma management	26
Two is better than one: longitudinal detection and volumetric evaluation of brain metastases after Stereotactic Radiosurgery with a deep learning pipeline	25
Congress of Neurological Surgeons systematic review and evidence‑based guidelines on the management of recurrent diffuse low-grade glioma: update	25
Immunotherapy approaches for the treatment of relapsed or progressive medulloblastoma	25
Journal of Neuro-Oncology, Meningioma issue	24
Differentiating radiation necrosis from tumor recurrence: a systematic review and diagnostic meta-analysis comparing imaging modalities	24
Patterns of response following gamma knife radiosurgery for tectal plate gliomas	24
Same but different. Incidental and symptomatic lower grade gliomas show differences in molecular features and survival	24
Early and late structural brain changes after radiation therapy: an MRI study in glioma patients	23
Bevacizumab in recurrent glioblastoma: does dose matter? Our monocentric and comparative experience	23
Procedural volume is linearly associated with mortality, major complications, and readmissions in patients undergoing malignant brain tumor resection	23
Patterns of treatment and outcomes of patients with brain-only metastatic breast cancer	22
The utility of long-term methylphenidate in preserving intellectual development in survivors of childhood brain tumour	22
Integration of molecular pathology with histopathology to accurately evaluate the biological behaviour of WHO grade 2 meningiomas and patient prognosis	22
Predicting post-surgical functional status in high-grade glioma with resting state fMRI and machine learning	22
Incidence, management, and outcome of incidental meningioma: what has happened in 10 years?	22
Management and treatment of brain tumors during pregnancy: an Italian survey	22
The concept, intention, and evaluation of the term treatment-refractory meningioma	22
Correction to: MiR-101-3p inhibits EMT to attenuate proliferation and metastasis in glioblastoma by targeting TRIM44	21
Brain metastases from ovarian cancer: neuroradiological profile and survival overview of neurosurgical cases	21
Correction to: Undetected pseudoprogressions in the CeTeG/NOA-09 trial: hints from postprogression survival and MRI analyses	21
Prevalence, therapeutic approaches, and survival rates of brain metastases in non-small cell lung cancer: a multi-institutional claims-based study from 2014 to 2024	20
Correction to: A prospective study of minimally invasive keyhole craniotomy and stereotactic brachytherapy for new brain oligometastases	20
Correction to: Impact of boost sequence in concurrent chemo-radiotherapy on newly diagnosed IDH-wildtype glioblastoma multiforme	20
Implications and interchangeability of meningioma biomarkers for clinical trials and clinical practice	20
Correction to: Leveraging single-cell sequencing to classify and characterize tumor subgroups in bulk RNA-sequencing data	20
Suberanilohydroxamic acid (SAHA), a HDAC inhibitor, suppresses the effect of Treg cells by targeting the c-Myc/CCL1 pathway in glioma stem cells and improves PD-L1 blockade therapy	19
Intrathecal anti-PD-1 treatment in metastatic melanoma patients with leptomeningeal disease (LMD): real-world data and evidence	19
Incidence, molecular characteristics, and imaging features of “clinically-defined pseudoprogression” in newly diagnosed glioblastoma treated with chemoradiation	19
Immune checkpoint inhibition and single fraction stereotactic radiosurgery in brain metastases from non-small cell lung cancer: an international multicenter study of 395 patients	19
Raman and autofluorescence spectroscopy for in situ identification of neoplastic tissue during surgical treatment of brain tumors	19
Neuroradiological features of patients with bilateral macronodular adrenocortical disease and meningiomas associated or not with genetic variants of ARMC5– a case series	19
The role of spine stereotactic radiosurgery for patients with breast cancer metastases	19
Salvage dacomitinib plus intraventricular pemetrexed for leptomeningeal metastasis after failure of third‑generation EGFR‑TKIs in EGFR‑mutant NSCLC: an ambispective cohort study	19
Chemotherapy is an efficient treatment in primary CNS MALT lymphoma	19
First-in-human sonodynamic therapy with ALA for pediatric diffuse intrinsic pontine glioma: a phase 1/2 study using low-intensity focused ultrasound	18
The use of telemedicine in pre-surgical evaluation: a retrospective cohort study of a neurosurgical oncology practice	18
Patterns and predictors of anxiety and depression symptom trajectories in patients diagnosed with primary brain tumors	18
Craniospinal irradiation for CNS leukemia: rates of response and durability of CNS control	18
The evolving role of reirradiation in the management of recurrent brain tumors	18
Letter to the editor: the impact of systemic treatment on brain metastases should be considered in clinical outcome analysis	18
Comparative efficacy and safety of sodium fluorescein-guided surgery versus standard white light for resection of brain metastases: a systematic review and meta-analysis	17
Radiotherapeutic advances in the management of glioblastoma	17
Genome-wide association study on meningioma risk in Japan: a multicenter prospective study	17

Stereotactic radiosurgery ensures an effective and safe long-term control of Koos grade IV vestibular schwannomas: a single-center, retrospective, cohort study	17
IDH1 mutation is associated with improved resection rates, progression-free survival and overall survival in patients with anaplastic astrocytomas	17
Re-irradiation for recurrent high-grade glioma: an analysis of prognostic factors for survival and predictors of radiation necrosis	17
The Journal of Neuro-Oncology: the last and next 40 years	17
China National Glioma Registry (CNGR): protocol for a prospective observational registry study	16
Comment on “The 5-factor modified frailty index as a prognostic factor for stereotactic radiosurgery in meningioma management”	16
Ciprofol reduces postoperative glioma recurrence by promoting MAPK11-PML phosphorylation: insights from transcriptomic and proteomic analysis	16
ANG peptide-modified exosomes loaded with oleanolic acid target GPX4 for enhanced breast cancer brain metastasis therapy	16
Risk calculator for long-term survival prediction of spinal chordoma versus chondrosarcoma: a nationwide analysis	16
Intratumoral tocilizumab in children with cystic craniopharyngiomas: targeted therapy	16
Preoperative assessment of eloquence in neurosurgery: a systematic review	16
Correction to: Acute side effects of proton and photon radiotherapy for medulloblastoma: a retrospective national multicenter study	16
Low tumour burden is associated with observation after surgery in patients with grade 2 astrocytoma and oligodendroglioma: results from the prospective multicentre LoG-Glio registry	16
Combined stereotactic radiotherapy and immunotherapy improves survival in driver-gene-negative NSCLC patients with brain oligo-metastases: a multicenter real-world study	16
Structural organization of neurosurgical care and its influence on long-term outcomes in glioma: evidence from a large single-center cohort in China	15
Can we make it up? - second-look surgery due to post-operative residual tumour in patients diagnosed with diffuse glioma	15
The state of art of awake craniotomy in Latin American countries: a scoping review	15
Initial results of a phase II trial of 18F-DOPA PET-guided re-irradiation for recurrent high-grade glioma	15
Differences in regional developmental origins of glioblastomas revealed by integrated molecular profiling	15
Congress of Neurological Surgeons systematic review and evidence-based guidelines for the role of chemotherapy in newly diagnosed WHO Grade II diffuse glioma in adults: update	15
Genetic predictors of neurocognitive outcomes in survivors of pediatric brain tumors	15
Repurposing mebendazole against triple-negative breast cancer CNS metastasis	15
Reirradiation versus systemic therapy versus combination therapy for recurrent high-grade glioma: a systematic review and meta-analysis of survival and toxicity	15
Real-world cost- effectiveness analysis: Tumor Treating Fields for newly diagnosed glioblastoma in China	15
Circadian variation in MGMT promoter methylation and expression predicts sensitivity to temozolomide in glioblastoma	15
Pre-treatment systemic inflammation response index and systemic immune inflammation in patients with primary central nerve system lymphoma as a useful prognostic indicator	15
Junctional adhesion molecular 3 (JAM3) is a novel tumor suppressor and improves the prognosis in breast cancer brain metastases via the TGF-β/Smad signal pathway	15
The role of cesium-131 brachytherapy in brain tumors: a scoping review of the literature and ongoing clinical trials	15
Clinical predictors of pseudoprogression in glioblastoma: a retrospective cohort analysis	15
The 4S of spinal astrocytoma: specific location, syrinx, spasticity and score on Modified Mccormick Scale (MMS) predict long term outcomes in patients undergoing surgical resection of intramedullary s	14
Stereotactic radiosurgery for patients with spinal metastases from prostate cancer	14
Targeting COL5A1 enhances anoikis thus attenuating malignancy of glioblastoma via inhibiting the Wnt/β-catenin signaling pathway	14
NUDT21 alters glioma migration through differential alternative polyadenylation of LAMC1	14
The impact of the molecular and genetic properties of glioblastoma on patient outcomes following stereotactic radiosurgery at recurrence	14
Effect of bevacizumab on non-target intracranial meningiomas and non-vestibular schwannomas in NF2-related schwannomatosis: NF104	14
Survival of nervous system tumors in a Colombian population cancer registry	14
Immune checkpoint inhibitors for glioblastoma: emerging science, clinical advances, and future directions	14
Cystic glioblastoma IDH-wildtype: genetic alterations and outcomes	14
Letter to the editor: surgeon experience in glioblastoma surgery of the elderly—a multicenter, retrospective cohort study	14
Identification of incidental brain tumors in prostate cancer patients via PSMA PET/CT	14
Clinical outcomes of three-fraction versus five-fraction stereotactic radiosurgery for resected brain metastases	14
Brain metastases from colorectal cancer – a retrospective dual center study	14
Study of prediction model for high-grade meningioma using fractal geometry combined with radiological features	14
Evaluating the role of gross total resection in primary spinal cord glioblastoma: evidence from a multicenter cohort and meta-analysis	14
Outcomes of radiation-induced meningiomas treated with stereotactic radiosurgery	14
The diagnostic efficiency of integration of 2HG MRS and IVIM versus individual parameters for predicting IDH mutation status in gliomas in clinical scenarios: A retrospective study	14
Tissue biopsy before resection in glioblastoma: is there an opportunity to improve outcomes with liquid biopsies and pre-operative stereotactic radiosurgery?	14
Elevating the findings by substituting in “ISarcoPRM”	14
Anatomical and surgical characteristics correlate with pachymeningeal failure in patients with brain metastases after neurosurgical resection and adjuvant stereotactic radiosurgery	14
Improved outcomes for triple negative breast cancer brain metastases patients after stereotactic radiosurgery and new systemic approaches	14
Static FET PET radiomics for the differentiation of treatment-related changes from glioma progression	14
ABTC-0904: targeting glioma stem cells in GBM: a phase 0/II study of hedgehog pathway inhibitor GDC-0449	14
Standardizing connectome-based brain tumor surgery through a network-based surgical nomenclature	14
The prognostic significance of HIST1H3B/C and H3F3A K27M mutations in diffuse midline gliomas is influenced by patient age	14
Postoperative stereotactic radiosurgery for intracranial solitary fibrous tumors: systematic review and pooled quantitative analysis	14
Anatomical changes in resection cavity during brain radiotherapy	14
CAR-engineered NK cells versus CAR T cells in treatment of glioblastoma; strength and flaws	13
The CCL2-CCR4 axis promotes Regulatory T cell trafficking to canine glioma tissues	13
Targeting ataxia-telangiectasia mutated and cystine/glutamate antiporter enhances radiotherapy efficacy and tumor suppression in glioblastoma	13
Impact of proton versus photon radiotherapy on overall survival in the management of spinal chordoma and mortality risk prediction: a nationwide analysis	13
High-dose furmonertinib combined with intraventricular chemotherapy as salvage therapy for leptomeningeal metastasis from EGFR exon 20 insertion-mutated lung cancer	13
Advanced imaging characterization of post-chemoradiation glioblastoma stratified by diffusion MRI phenotypes known to predict favorable anti-VEGF response	13
An exploratory prospective phase II study of preoperative neoadjuvant bevacizumab and temozolomide for newly diagnosed glioblastoma	13
Identification of NEK6 as a potential biomarker for prognosis in glioma and its functional implications	13
Hypofractionated vs. conventional fractionated radiotherapy in the temozolomide era for elderly patients with glioblastoma: a systematic review and meta-analysis by the Korean Society for Neuro-Oncolo	13
CRYM suppresses glioblastoma progression by inhibiting the TGFβ1/Smad-EMT signaling pathway	13
Phase I study targeting newly diagnosed grade 4 astrocytoma with bispecific antibody armed T cells (EGFR BATs) in combination with radiation and temozolomide	13
Glioblastoma survival in rural America: a 10-year experience from a quaternary care center	13
Prognostic significance of H3.K27me3 loss in CNS WHO grade 2 meningiomas: a multicentre clinicopathological study	13
Seizure outcomes after resection of primary brain tumors in pediatric patients: a systematic review and meta-analysis	13
Pre-operative blood-based inflammatory indices and long-term facial nerve outcomes following vestibular schwannoma resection	13
Baseline characteristics of adults with neurofibromatosis enrolled on a psychosocial randomized controlled trial	13
Patient-derived glioma organoids real time identification of IDH mutation, 1p/19q-codeletion and CDKN2A/B homozygous deletion with differential ion mobility spectrometry	13
The role of MRI patterns in predicting neurologic deficits in spinal ependymomas	13
Outcomes following radiation therapy for embryonal tumor with multilayered rosettes (ETMR): results from the Pediatric Proton/Photon Consortium Registry (PPCR)	13
Factors associated with cognitive impairment in long-term IDH-mutant glioma survivors	13
Roles and outcomes of stereotactic biopsy for adult patients with brainstem lesion	13
Histopathological correlation of brain tumor recurrence vs. radiation effect post-radiosurgery as detected by MRI contrast clearance analysis: a validation study	13
Management of chordoma and chondrosarcoma with definitive dose-escalated single-fraction spine stereotactic radiosurgery	13
Prediction of double expression status of primary CNS lymphoma using multiparametric MRI radiomics combined with habitat radiomics: a double-center study	13

Long-term outcomes of modern radiation therapy for pituitary adenoma – different techniques: single institute experience	13
Long-term outcomes of central neurocytoma – an institutional experience	12
Repeated stereotactic radiosurgery for high grade meningioma	12
Exploring the prognostic value of BRMS1 + microglia based on single-cell anoikis regulator patterns in the immunologic microenvironment of GBM	12
Radiation-sparing management of WNT medulloblastoma of early childhood with high dose chemotherapy: In response to Gupta et al	12
Surgeon experience in glioblastoma surgery of the elderly—a multicenter, retrospective cohort study	12
Resection of craniopharyngiomas: comparison between gross total resection and subtotal resection with adjuvant radiation	12
Awake craniotomy for brain tumor resection in the elderly: an institutional experience	12
Preoperative frailty measured by risk analysis index predicts complications and poor discharge outcomes after Brain Tumor Resection in a large multi-center analysis	12
Advanced imaging reveals enhanced malignancy in glioblastomas involving the subventricular zone: evidence of increased infiltrative growth and perfusion	12
Efficacy and safety of immune checkpoint inhibitors plus anlotinib in small cell lung cancer with brain metastases: a retrospective, multicentre study	12
Correction to: Intrathecal chemotherapy for leptomeningeal disease in high-grade gliomas: a systematic review	12
Single-fraction Gamma Knife radiosurgery for pineal region meningiomas: a retrospective single-center cohort of 44 patients	12
Disrupting Akt-Wnt/β-catenin signaling suppresses glioblastoma stem cell growth and tumor progression in immunocompetent mice	12
The relationship between asthma and glioma: a case-control study in a universal access healthcare system	12
NOTCH3 drives fatty acid oxidation and ferroptosis resistance in aggressive meningiomas	12
Racial disparities in the management and outcomes of primary osseous neoplasms of the spine: a SEER analysis	11
Validation of the initial brain metastasis velocity in non-small cell lung cancer at a single cancer center	11
Frequency of and risk factors associated with local recurrence after spinal stereotactic body radiation therapy without surgery	11
Association between thyroid function and regorafenib efficacy in patients with relapsed wild-type IDH glioblastoma: a large multicenter study	11
Repeat surgery of recurrent glioma for molecularly informed treatment in the age of precision oncology: A risk–benefit analysis	11
Particle beam radiotherapy in the treatment of WHO grade 2 and 3 meningiomas: an early experience from Shanghai Proton and Heavy Ion Center	11
Gamma knife radiosurgery for breast cancer brain metastasis: survival outcomes, prognotic factors, and the role of repeat treatment	11
Long-term outcomes of fractionated proton beam therapy for benign or radiographic intracranial meningioma	11
Large vestibular schwannoma treated using a cranial nerve sparing approach with planned subtotal microsurgical resection and stereotactic radiosurgery: meta-analysis and International Stereotactic Rad	11
Comment on “Amino-acid PET as a prognostic tool after post-stupp protocol temozolomide therapy in high-grade glioma patients”	11
Regression of sporadic CNS hemangioblastomas with belzutifan	11
Pharmaceutical equivalent 5-aminolevulinic acid fluorescence guided resection of central nervous system tumors: feasibility, safeness and cost-benefit considerations	11
The cognitive functions and seizure outcomes of patients with low-grade epilepsy-associated neuroepithelial tumors	11
Clinical Course after Carmustine Wafer Implantation for Newly Diagnosed Adult-type Diffuse Gliomas; A controlled propensity matched analysis of a single center cohort	11
Stereotactic body radiation therapy for spinal metastases from gastrointestinal primary cancers	11
Computerized assessment of neuropsychological functioning in pediatric brain tumor patients	11
Superficial meningioma with bone involvement: surgical strategies and clinical outcomes	11
Study of Strawberry Notch homolog 1 and 2 expression in human glioblastoma	11
Fractionated pre-operative stereotactic radiotherapy for patients with brain metastases: a multi-institutional analysis	11
Prognostic significance of MRI contrast enhancement in newly diagnosed glioblastoma, IDH-wildtype according to WHO 2021 classification	11
Postoperative absence of residual intracranial tumor volume is associated with improved survival and intracranial disease control in non-small cell lung cancer brain metastases	11
Evaluation of clinical and volumetric outcomes following adaptive gamma knife radiosurgery for brain metastases	11
Correction to: The characteristics of brain structural remodeling in patients with unilateral vestibular schwannoma	11
Neuropsychological impairment in primary malignant brain tumor patients with awake craniotomy: a hospital-based registration study	11
Physical function, body mass index, and fitness outcomes in children, adolescents, and emerging adults with craniopharyngioma from proton therapy through five years of follow-up	10
Investigating the effects of PTEN mutations on cGAS-STING pathway in glioblastoma tumours	10
The “Combo” radiotherapy treatment for high-risk grade 2 meningiomas: dose escalation and initial safety and efficacy analysis	10
Clinical and neuropathological criteria for distinguishing between IDH-mutant astrocytomas of WHO grade 2 and 3	10
Impact of seizures and antiseizure medication on survival in patients with glioma	10
Algorithm-based assessment of T-cell dysfunction and exclusion to forecast ICB sensitivity in pediatric brain ependymoma	10
IDH1 p.R132H ctDNA and D-2-hydroxyglutarate as CSF biomarkers in patients with IDH-mutant gliomas	10
Systemic immune-inflammation index as a prognostic biomarker to predict overall survival after primary stereotactic radiosurgery for brain metastases	10
Interstitial photodynamic therapy for newly diagnosed glioblastoma	10
DNA damage in IDH-mutant gliomas: mechanisms and clinical implications	10
Correction to: Prognostic relevance and cytokine correlates of peripheral immune subpopulations in newly diagnosed glioblastoma	10
Enhancing radiation sensitivity in malignant brain tumors with chloroquine: a systematic review	10
Is reduced-dose whole-brain radiotherapy also feasible in primary CNS lymphoma for curative or salvage purpose?	10
Comparative safety and survival outcomes of immune checkpoint inhibitors in brain metastases from lung cancer: a propensity-matched cohort study	10
National and institutional capacity building with international collaboration to advance pediatric neuro-oncology care in Ethiopia: a baseline need assessment survey	10
Additive risk of surgical site infection from more than one risk factor following craniotomy for tumor	10
Construction and application of an ERAS-based nursing pathway for postoperative pain management in brain tumor patients	10
Tumor-related epilepsy in high-grade glioma: a large series survival analysis	10
Posterior fossa syndrome in a population of children and young adults with medulloblastoma: a retrospective, multicenter Italian study on incidence and pathophysiology in a histologically homogeneous	10
Likelihood-of-harm/help of microsurgery compared to radiosurgery in large vestibular schwannoma	10
Impact of brain metastasis size at the time of radiotherapy on local control and radiation necrosis	10
Multimodal treatment of glioblastoma with multiple lesions - a multi-center retrospective analysis	10
The role of GammaTile in the treatment of brain tumors: a technical and clinical overview	10
The promise and potential of porphyrin metabolite activation using sonodynamic therapy for the treatment of glioblastoma	10
Factors affecting postoperative seizure risk and perioperative outcomes in pediatric brain tumor resections	10
The association of hospital volume status with treatment and survival outcomes of intracranial meningioma patients: a multivariable analysis of the National Cancer Database	10
Prognostic factors for pediatric, adolescent, and young adult patients with non-DIPG grade 4 gliomas: a contemporary pooled institutional experience	10
High-grade glioma imaging volumes and survival: a single-institution analysis of 101 patients after resection using intraoperative MRI	10
Short-term sensorimotor training incorporating cognitive tasks for pediatric survivors of posterior fossa tumors: a pilot study	10
Correction to: Umbrella review and network meta-analysis of diagnostic imaging test accuracy studies in differentiating between brain tumor progression versus pseudoprogression and radionecrosis	10
Surgical characteristics and survival outcomes of pediatric pineal region tumors: a cohort study in Vietnam	10
Correction to: Early EEG hyperexcitability is associated with decreased survival in newly diagnosed IDH-wildtype glioma	10
Treatment outcomes for response-based radiotherapy in children and adolescents with central nervous system germinoma: a prospective study	10
Medulloblastoma in adults: evaluation of the Dutch society for neuro-oncology treatment protocol	10
Meningioma in patients exposed to progestin drugs: results from a real-life screening program	10
The dynamic nature of frailty in metastatic spine disease patients	10
Epidemiology of WHO grade 2 and grade 3 gliomas from 2009 to 2021 in Germany	10
Transcriptome sequencing analysis revealed the molecular mechanism of BNCT inhibiting the growth of U87 subcutaneous tumor	10
Expression of ABCB1, ABCC1 and 3 and ABCG2 in glioblastoma and their relevance in relation to clinical survival surrogates	10
Breast cancer brain metastases localization and risk of hydrocephalus: a single institution experience	10
Prognostic relevance of resection at first recurrence in isocitrate dehydrogenase mutant lower-grade glioma: results from a retrospective, single-center, volumetric analysis	10
T7 peptide-decorated exosome-based nanocarrier system for delivery of Galectin-9 siRNA to stimulate macrophage repolarization in glioblastoma	10
Focused ultrasound combined with radiotherapy for malignant brain tumor: a preclinical and clinical study	10
Overexpression of LSR suppresses glioma proliferation and invasion via regulating FOXO3a	10
Perilesional resection technique of glioblastoma: intraoperative ultrasound and histological findings of the resection borders in a single center experience	10
Demographic variations and time to initiation of adjunct treatment following surgical resection of anaplastic astrocytoma in the United States: a National Cancer Database analysis	10
Correction to: Efficacy and safety of BRAF-MEK dual inhibition in BRAF-V600E mutated papillary craniopharyngioma: a systematic review	10
The magnitude of surgical site infection and its associated factors among pediatric central nervous system (CNS) tumor patients at tertiary referral hospitals in Ethiopia: a multi-center study	10
The patients’ experience of neuroimaging of primary brain tumors: a cross-sectional survey study	10
Rapid detection of mutations in CSF-cfTNA with the Genexus Integrated Sequencer	9
Readmission risk of malignant brain tumor patients undergoing laser interstitial thermal therapy (LITT) and stereotactic needle biopsy (SNB): a covariate balancing weights analysis of the National Rea	9
Post-ablation volume threshold for brain metastasis control using LITT: a systematic review and critical appraisal	9
Neurocognitive functioning after Gamma Knife and LINAC stereotactic radiosurgery in patients with brain metastases	9
Clinical and genomic profiles of malignant peripheral nerve sheath tumors in the craniospinal axis	9
White matter connectivity and social functioning in survivors of pediatric brain tumor	9